161 related articles for article (PubMed ID: 9239163)
21. [Combination chemotherapy of TS-1 +cisplatin for inoperable gastric cancer].
Koizumi W; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Nagaba S; Azuma M; Shimoda T; Nishimura K; Nakatani K; Saigenji K
Gan To Kagaku Ryoho; 2004 Nov; 31(12):1957-61. PubMed ID: 15570920
[TBL] [Abstract][Full Text] [Related]
22. [Biochemical modulation of 5-FU--effect of low dose CDDP].
Hirata K; Yamamitsu S; Tsuji A; Shirasaka T; Mukaiya M; Oikawa I; Kimura H; Sasaki K; Denno R
Gan To Kagaku Ryoho; 1999 Mar; 26(4):467-75. PubMed ID: 10097743
[TBL] [Abstract][Full Text] [Related]
23. [Effect of sodium thiosulfate on the antitumor effect and nephrotoxicity of CDDP in human gastric cancer transplanted in nude mice].
Saito D; Fujii T; Yoshida S; Ohkura H; Oguro Y
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 1):379-85. PubMed ID: 2930203
[TBL] [Abstract][Full Text] [Related]
24. [Theoretical basis for low-dose CDDP/5-FU therapy].
Kubota T
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1536-41. PubMed ID: 10553409
[TBL] [Abstract][Full Text] [Related]
25. Combination chemotherapy with JTE-522, a novel selective cyclooxygenase-2 inhibitor, and cisplatin against gastric cancer cell lines in vitro and in vivo.
Sugiura T; Saikawa Y; Kubota T; Suganuma K; Otani Y; Watanabe M; Kumai K; Kitajima M
In Vivo; 2003; 17(3):229-33. PubMed ID: 12929571
[TBL] [Abstract][Full Text] [Related]
26. [Antitumor activity and function of S-1, a new oral tegafur-based formulation].
Fukushima M
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():19-26. PubMed ID: 16897968
[TBL] [Abstract][Full Text] [Related]
27. [Antitumor activity of BOF-A2, a new 5-fluorouracil derivative, against human cancers xenografted in nude mice by intermittent administration].
Fujita F; Fujita M; Inaba H; Taguchi T
Gan To Kagaku Ryoho; 1993 Feb; 20(2):223-8. PubMed ID: 8434959
[TBL] [Abstract][Full Text] [Related]
28. [A Case of advanced gastric cancer successfully treated with TS-1/low-dose CDDP as neoadjuvant chemotherapy].
Yamada K; Sugiyama Y; Seino K; Kobori H; Ebina T; Shibata S; Kawasaki H; Sasaki M; Tanaka M
Gan To Kagaku Ryoho; 2005 Oct; 32(10):1447-51. PubMed ID: 16227746
[TBL] [Abstract][Full Text] [Related]
29. [Low-dose FP therapy for advanced and recurrent gastric cancer].
Yamashita Y; Ohira M; Sowa M; Shirasaka T; Hirakawa K; Chung YS
Gan To Kagaku Ryoho; 1999 Oct; 26(11):1548-53. PubMed ID: 10553411
[TBL] [Abstract][Full Text] [Related]
30. [Combined 5-FU and CDDP in a gastric cancer patient undergoing hemodialysis--pharmacokinetics of 5-FU and CDDP].
Cho H; Imada T; Masudo K; Doi C; Inaba M; Tokunaga M; Takanashi Y
Gan To Kagaku Ryoho; 2000 Nov; 27(13):2135-8. PubMed ID: 11103248
[TBL] [Abstract][Full Text] [Related]
31. [A novel combined chemotherapy using TS-1 and low-dose cisplatin against liver metastasis of gastric cancer].
Saikawa Y; Kanai T; Kawano Y; Otani Y; Kubota T; Kitajima M
Gan To Kagaku Ryoho; 2002 Jul; 29(7):1241-5. PubMed ID: 12146007
[TBL] [Abstract][Full Text] [Related]
32. Combined effect of CDDP and caffeine against human gastric cell line in vivo.
Takahashi M; Yanoma S; Yamamoto Y; Rino Y; Amano T; Imada T
Anticancer Res; 1998; 18(6A):4399-401. PubMed ID: 9891499
[TBL] [Abstract][Full Text] [Related]
33. A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment method.
Morita S; Nakata B; Tsuji A; Mitachi Y; Shirasaka T; Saji S; Ohashi Y; Sakamoto J; Hirakawa K
Jpn J Clin Oncol; 2007 Dec; 37(12):924-9. PubMed ID: 18211983
[TBL] [Abstract][Full Text] [Related]
34. [Effect of cisplatin (CDDP) against peritonitis carcinomatosa in nude mice inoculated intraperitoneally with human gastric cancer].
Takao S; Nomura H; Aikou T; Maenohara S; Saihara T; Kajisa T; Nishi M
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1638-43. PubMed ID: 3896155
[TBL] [Abstract][Full Text] [Related]
35. [Effects of separate administration of low-dose CDDP on antitumor immune reactivity for treatment of malignant glioma].
Nishihara T; Tanaka S; Murakami M; Hirakawa M; Nagashima T
Gan To Kagaku Ryoho; 1995 Aug; 22(9):1197-202. PubMed ID: 7661572
[TBL] [Abstract][Full Text] [Related]
36. Phase I study of the sequential administration of S-1 and cisplatin for metastatic gastric cancer.
Baba E; Fujishima H; Kusaba H; Esaki T; Ariyama H; Kato K; Tanaka R; Mitsugi K; Shibata Y; Harada M; Nakano S
Anticancer Res; 2009 May; 29(5):1727-32. PubMed ID: 19443394
[TBL] [Abstract][Full Text] [Related]
37. Antitumour activity of cis-diamminedichloroplatinum (II) against human tumour xenografts depends on its area under the curve in nude mice.
Kurihara N; Kubota T; Hoshiya Y; Otani Y; Watanabe M; Kumai K; Kitajima M
J Surg Oncol; 1996 Feb; 61(2):138-42. PubMed ID: 8606546
[TBL] [Abstract][Full Text] [Related]
38. [Two elderly patients with advanced gastric cancer responding to chronomodulation chemotherapy with tegafur + cisplatin + isovorin followed by oral administration of S-1].
Kobayashi A; Yamaguchi M
Gan To Kagaku Ryoho; 2001 Jul; 28(7):1003-7. PubMed ID: 11478129
[TBL] [Abstract][Full Text] [Related]
39. [Two patients with StageIV gastric cancer responding to combination therapy with S-1 and low-dose CDDP after reduction surgery].
Sugie T; Nagai T; Ohgaki K
Gan To Kagaku Ryoho; 2007 May; 34(5):765-8. PubMed ID: 17496454
[TBL] [Abstract][Full Text] [Related]
40. [A case of unresectable advanced gastric cancer with peritoneal dissemination responding to UET/low-dose CDDP combination chemotherapy].
Baba M; Higaki N; Nishihara M; Ishida M; Kawasaki H; Sasayama Y
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2541-4. PubMed ID: 12506479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
